KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nektar Therapeutics (NKTR) Deferred Taxes: 2020-2023

Historic Deferred Taxes for Nektar Therapeutics (NKTR) over the last 4 years, with Dec 2023 value amounting to -$140,000.

  • Nektar Therapeutics' Deferred Taxes fell 106.67% to -$31,000 in Q3 2024 from the same period last year, while for Sep 2024 it was $1.7 million, marking a year-over-year increase of 99.30%. This contributed to the annual value of -$140,000 for FY2023, which is 105.17% down from last year.
  • Per Nektar Therapeutics' latest filing, its Deferred Taxes stood at -$140,000 for FY2023, which was down 105.17% from $2.7 million recorded in FY2022.
  • In the past 5 years, Nektar Therapeutics' Deferred Taxes registered a high of $2.7 million during FY2022, and its lowest value of -$140,000 during FY2023.
  • Over the past 3 years, Nektar Therapeutics' median Deferred Taxes value was -$102,000 (recorded in 2021), while the average stood at $822,000.
  • As far as peak fluctuations go, Nektar Therapeutics' Deferred Taxes slumped by 183.33% in 2021, and later spiked by 2,754.90% in 2022.
  • Nektar Therapeutics' Deferred Taxes (Yearly) stood at -$36,000 in 2020, then slumped by 183.33% to -$102,000 in 2021, then skyrocketed by 2,754.90% to $2.7 million in 2022, then plummeted by 105.17% to -$140,000 in 2023.